Specific active immunotherapy in lung cancer: the induction of long-lasting cellular responses to tumour-associated antigens.
D000951:Antigens, Neoplasm / Q000276:immunology; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000276:immunology / Q000628:therapy*; D008727:Methotrexate / Q000627:therapeutic use; D009367:Neoplasm Staging
D000951:Antigens, Neoplasm; D008727:Methotrexate